The Impact of the Hypnosis on the Loss of Weight at Patients in Failure of Bariatric Surgery
Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Mar 26, 2018
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of hypnosis on weight loss in patients who have had bariatric surgery but are struggling to lose weight. Bariatric surgery can help many people with severe obesity, but about 25% of patients do not lose enough weight after two years. This study is exploring whether adding hypnosis to regular diet monitoring can help these patients change their eating habits, reduce anxiety and stress, and improve their self-esteem.
To participate in the trial, you must be an adult aged 18 to 65 who is considered obese and has not lost enough weight after bariatric surgery. You should also be able to attend all study visits and follow the procedures. Unfortunately, if you are currently pregnant, have certain serious health conditions, or have specific mental health issues, you may not be eligible. If you join the study, you can expect to receive hypnotherapy along with standard dietary advice to help you on your weight loss journey.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Obese patient (BMI = 30 kg / m ²)
- • 18 - 65 years ( inclusive borders)
- • Patient in failure of bariatric surgery and in which no surgical resumption can be proposed (in view of Reinhold's classification, the failure will be considered as a loss of overweight lower than 50 % in two years further to a bariatric surgery).
- • Informed consent
- • Patient in measure to realize all the visits and to follow the procedures of the study - Subject affiliated to a social security system
- Exclusion criteria:
- • Pregnancy current or planned during the duration of the study, pregnant or breast-feeding women
- • Craniopharyngioma or any other evolutionary malignant pathology, or chronic illness in decompensation phase
- • Strong probability of not compliance to the protocol or drop-out
- • Psychiatric pathology of dissociated type (schizophrenia; psychosis, bipolarity ...)
- • Sensory (hearing, visual) or cognitive deficits susceptible to hinder the progress of the sessions.
- • Incapacity to understand the nature and the purpose of the study and\\or communication difficulties with the investigator
- • Patient having already benefited from a coverage by hypnotherapy for loss of weight
- • Taken by treatment having an impact on the loss of weight (corticoid, antithyroid ...)
- • Major protected by the law or considered vulnerable (under guardianship)
About University Hospital, Montpellier
The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
Reims, , France
La Réunion, , France
Montpellier, , France
Orléans, , France
Patients applied
Trial Officials
David NOCCA, PU-PH
Principal Investigator
University Hospital, Montpellier
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials